{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:43:52Z","timestamp":1781916232034,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007337","name":"Massachusetts Eye and Ear","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ajoc.2020.100652","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T12:23:26Z","timestamp":1583497406000},"page":"100652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Checkpoint inhibitor-induced sarcoid choroidal granulomas"],"prefix":"10.1016","volume":"18","author":[{"given":"Cindy","family":"Ung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2437-5283","authenticated-orcid":false,"given":"Evangelos","family":"Gragoudas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajoc.2020.100652_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCO.0000000000000296","article-title":"Ocular and orbital side-effects of checkpoint inhibitors: a review article","volume":"28","author":"Antoun","year":"2016","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100652_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14737140.2017.1296765","article-title":"Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review","volume":"17","author":"Abdel-Rahman","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100652_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13613-019-0487-x","article-title":"Severe toxicity from checkpoint protein inhibitors: what intensive care physicians need to know?","volume":"9","author":"Lemiale","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ajoc.2020.100652_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/OTT.S57335","article-title":"Ipilimumab in the treatment of metastatic melanoma: management of adverse events","volume":"7","author":"Della Vittoria Scarpati","year":"2014","journal-title":"OncoTargets Ther"},{"issue":"6","key":"10.1016\/j.ajoc.2020.100652_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100652_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.joco.2019.05.002","article-title":"Ocular adverse events with immune checkpoint inhibitors","volume":"31","author":"Fang","year":"2019","journal-title":"J Curr Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2020.100652_bib7","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.chest.2015.10.082","article-title":"Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma","volume":"149","author":"Danlos","year":"2016","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100652_bib8","doi-asserted-by":"crossref","DOI":"10.4161\/21624011.2014.954506","article-title":"Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab","volume":"3","author":"Andersen","year":"2014","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100652_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdcr.2017.02.015","article-title":"Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma","volume":"3","author":"Birnbaum","year":"2017","journal-title":"JAAD Case Rep"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100652_bib10","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/1078155216667635","article-title":"Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitors","volume":"23","author":"Firwana","year":"2017","journal-title":"J Oncol Pharm Pract"},{"issue":"10","key":"10.1016\/j.ajoc.2020.100652_bib11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10147-019-01490-2","article-title":"Immune checkpoint inhibitor-induced sarcoidosis-like granulomas","volume":"24","author":"Rambhia","year":"2019","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100652_bib12","doi-asserted-by":"crossref","first-page":"e1068","DOI":"10.1097\/MJT.0000000000000266","article-title":"Ipilimumab-induced granulomatous disease occurring simultaneously with disease progression in a patient with metastatic melanoma","volume":"23","author":"Toumeh","year":"2016","journal-title":"Am J Therapeut"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100652_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jdcr.2016.06.004","article-title":"Pembrolizumab-associated sarcoidosis","volume":"2","author":"Cotliar","year":"2016","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100652_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/bjd.14808","article-title":"Pulmonary sarcoid-like granulomatosis induced by nivolumab","volume":"176","author":"Montaudie","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ajoc.2020.100652_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajoc.2016.12.014","article-title":"Multifocal choroiditis as the first sign of systemic sarcoidosis associated with pembrolizumab","volume":"5","author":"Lise","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"5-6","key":"10.1016\/j.ajoc.2020.100652_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000334239","article-title":"Sarcoid-like granulomatosis and testicular germ cell tumor: the 'Great Imitator","volume":"81","author":"Kaikani","year":"2011","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100652_bib17","first-page":"177","article-title":"Sarcoid reactions in primary pulmonary carcinoma: report of seven cases","volume":"5","author":"Kamiyoshihara","year":"1998","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.ajoc.2020.100652_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s005350170036","article-title":"Multiple early gastric cancer associated with sarcoid-like reaction in the regional lymph nodes","volume":"36","author":"Nakamura","year":"2001","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ajoc.2020.100652_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/bjd.12279","article-title":"Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases","volume":"169","author":"Green","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ajoc.2020.100652_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/CMR.0000000000000437","article-title":"Sarcoid-like reactions in patients receiving modern melanoma treatment","volume":"28","author":"Dimitriou","year":"2018","journal-title":"Melanoma Res"},{"issue":"4","key":"10.1016\/j.ajoc.2020.100652_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/IAE.0000000000000429","article-title":"Paraneoplastic sarcoid-like reactions and the eye","volume":"35","author":"Balasubramaniam","year":"2015","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.ajoc.2020.100652_bib22","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0161-6420(97)30148-1","article-title":"Survey of 520 eyes with uveal metastases","volume":"104","author":"Shields","year":"1997","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajoc.2020.100652_bib23","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.ophtha.2003.05.004","article-title":"Metastatic melanoma in the eye and orbit","volume":"110","author":"Zografos","year":"2003","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620300335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993620300335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:00:04Z","timestamp":1762527604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993620300335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":23,"alternative-id":["S2451993620300335"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100652","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Checkpoint inhibitor-induced sarcoid choroidal granulomas","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2020.100652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100652"}}